Fiocruz: Brazilian Covid-19 Vaccine Could Advance to Clinical Trials in 2021

Should these studies produce positive results over the next year, one of these vaccines is expected to be available in 2022.

RIO DE JANEIRO, BRAZIL - While preparing to produce the Covid-19 vaccine developed by AstraZeneca Pharmaceutical Company and Oxford University, the Oswaldo Cruz Foundation (Fiocruz . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?